~~<i id='8CDBC7B6A0'><strike id='8CDBC7B6A0'><tt id='8CDBC7B6A0'><pre id='8CDBC7B6A0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：entertainment 2025-09-03 03:26:42 - browse：5

A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat — PATRICK T. FALLON/AFP via Getty Images

You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

He had a point.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： NIH director takes cautious approach to Biden drug pricing priority

knowledge

entertainment

hotspot

knowledge

focus

leisure time

8:12BryanKohbergerentersthecourtroomforahearingattheLatahCountyCourthouse,June27,2023inMoscow,Idaho.

WSS

Aspartame and sugar

Illinois Supreme Court finds assault weapons ban constitutional

Judge sides with young activists in first

The surgeon had a dilemma only a Nazi medical text could resolve

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Eli Lilly, Pfizer, and others want in on the online prescription market

hotspot

fashion

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Biotech venture capitalists face new demands from investors

BioMarin wins approval for gene therapy to treat hemophilia A

Montana youths win climate lawsuit against state for promoting fossil fuels

How to save PrEP access — and even expand it

Dewpoint Therapeutics lays off staff after losing partnerships

Dobbs anniversary: the lost opportunity of abortion as health care

Humana cuts profit projections as Medicare Advantage costs soar

Heart attack and stroke risk calculators need revising

Why doctors need education on FDA device approval process

entertainment

EU regulator recommends expanding Mounjaro approval to obesity

Humana cuts profit projections as Medicare Advantage costs soar

Hospitals are dialing back on venture capital investing

Francis Collins on trust in science and how Covid communications failed

Medicare Advantage today, explained in one chart

Timeline: How the deadly wildfires took over Maui day by day

hotspot

knowledge

focus

leisure time